'No question about it, he is still a leader': Sharad Pawar says nephew Ajit Pawar still member of NCP

-

The chief of the Nationalist Congress Party (NCP) Sharad Pawar further expanded the scope of speculation over his nephew Ajit Pawar’s allegiance, saying that the Deputy Chief Minister of the BJP-ruled state of Maharashtra is still a leader of NCP.

On Friday, Sharad Pawar said that while some leaders have left the party by taking a “different political stand”, their exit cannot be termed a “split.”

Pawar was talking to reporters at his hometown Baramati in the Pune district in the morning before leaving for Kolhapur, where he is scheduled to address a rally later in the day.

Pawar’s comments come a day after his daughter and NCP’s working president Supriya Sule called Ajit Pawar a senior leader and MLA of the party.

She said, “Now, he (Ajit Pawar) has taken a stand that is against the party, and we have given a complaint to the assembly speaker and are awaiting his response.”

When asked if there is no split within the party and if Ajit Pawar still holds a status in NCP, Pawar senior said, ” Yes, there is no question about it. How can anybody say that there is a split in NCP? There’s no question that Ajit Pawar is our party leader.”

“What does a split in a political party mean? Split occurs when a large group in a party is separated at the national level. But no such thing has happened here. Some people left the party, some took a different stand…In democracy it is their right to take a decision,” he added.

Ajit Pawar and eight other NCP MLAs joined the Eknath Shinde-led Shiv Sena-Bharatiya Janata Party (BJP) government in the state on July 2.

Talking about the upcoming Lok Sabha elections, Pawar expressed confidence that the Maha Vikas Aghadi (MVA) comprising the NCP, Uddhav Thackeray-led Shiv Sena (UBT) and Congress, will perform better than the BJP-led National Democratic Alliance (NDA) in Maharashtra in the 2024 Lok Sabha elections.

With inputs from PTI



from Firstpost India Latest News https://ift.tt/csl26aU
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more